12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

• IGC Pharma (AMEX:IGC) shares moved upwards by 14.6% to $0.4 during Wednesday's after-market session. The market value of their outstanding shares is at $25.4 million.
• Establishment Labs Hldgs (NASDAQ:ESTA) shares rose 14.43% to $44.01. The market value of their outstanding shares is at $1.1 billion. The company's, Q4 earnings came out today.
• Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 11.44% to $10.0. The market value of their outstanding shares is at $555.6 million. As per the press release, Q4 earnings came out today.
• Natera (NASDAQ:NTRA) shares moved upwards by 9.73% to $84.0. The company's market cap stands at $10.0 billion. As per the press release, Q4 earnings came out today.
• MiMedx Group (NASDAQ:MDXG) shares increased by 9.14% to $8.95. The company's market cap stands at $1.3 billion. As per the press release, Q4 earnings came out today.
• Lexaria Bioscience (NASDAQ:LEXX) shares increased by 9.01% to $2.78. The market value of their outstanding shares is at $33.9 million.

Losers

• Butterfly Network (NYSE:BFLY) shares decreased by 16.9% to $1.23 during Wednesday's after-market session. The company's market cap stands at $254.7 million. As per the press release, Q4 earnings came out today.
• Ampio Pharmaceuticals (AMEX:AMPE) shares decreased by 10.87% to $2.05. The company's market cap stands at $2.3 million.
• ClearPoint Neuro (NASDAQ:CLPT) stock fell 10.63% to $6.9. The market value of their outstanding shares is at $169.8 million.
• Schrodinger (NASDAQ:SDGR) stock declined by 9.98% to $28.24. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today.
• GlucoTrack (NASDAQ:GCTK) shares fell 9.44% to $0.24. The market value of their outstanding shares is at $5.8 million.
• SILO Pharma (NASDAQ:SILO) shares fell 7.41% to $1.5. The market value of their outstanding shares is at $4.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.